INDORAMA NSE filing

Indo Rama Synthetics Reports Strong Q2/H1 FY26 Results, Appoints New CS, and Approves Related Party Transactions

The RealCase readHigh impact Positive

Indo Rama Synthetics reported strong Q2/H1 FY26 consolidated results with a significant profit turnaround. The board appointed a new CS and approved a postal ballot for related party transactions.

Why it matters

The announcement signifies a major financial improvement for the company, moving from a loss-making to a profit-making position with robust revenue and EBITDA growth. This, combined with a key management appointment and a material related party transaction requiring shareholder approval, makes the announcement highly impactful.

The market read

The company reported a substantial financial turnaround from losses to profits in both Q2 and H1 FY26, accompanied by significant growth in total income and EBITDA. This strong performance indicates improved operational efficiency and positive market conditions.

Indo Rama Synthetics (India) Limited's Board of Directors met on November 10, 2025, and took the following key decisions: * Approved the Un-audited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2025. * Noted the Limited Review Reports with unmodified opinions from the Statutory Auditors for both Standalone and Consolidated Financial Results. * Appointed Mr. Ashok Yadav (ACS 14223) as Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company, effective from November 10, 2025. * Authorized specific KMPs to disseminate material events or information to Stock Exchanges. * Modified the Policy on Materiality of Related Party Transactions. * Decided to seek consent from members through a Postal Ballot process to approve Material Related Party Transactions with TPT Petrochemicals Public Co. Limited, Thailand, for the financial year 2025-26. The cut-off date for ascertaining the list of members for the Postal Ballot is November 14, 2025.

Financial Highlights (Consolidated) for Q2 & H1 FY26: * Total Income for Q2 FY26 stood at ₹1,222.35 crore, a 28.23% increase over the same period last year. * Total Income for H1 FY26 reached ₹2,530.91 crore, marking a 33.30% increase over the same period last year. * EBITDA for Q2 FY26 was ₹80.38 crore, significantly up from ₹7.61 crore in Q2 FY25. * EBITDA for H1 FY26 was ₹180.65 crore, compared to ₹37.66 crore in H1 FY25, primarily due to rationalization of operational costs and improved margins. * Profit After Tax (PAT) for Q2 FY26 was ₹24.55 crore, a turnaround from a loss of ₹(44.08) crore in Q2 FY25. * PAT for H1 FY26 was ₹77.30 crore, a significant improvement from a loss of ₹(63.26) crore in H1 FY25.

Filing to action

What to do with a filing like this

Indo Rama Synthetics (India) Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Indo Rama Synthetics (India) Limited. Read the original for the full detail.

View original filing